Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism.
about
An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stabilityMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseEmerging role of microRNAs in lipid metabolismMicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosisNuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?The oncogenic role of Yin Yang 1Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesisRole of nuclear receptor SHP in metabolism and cancer.MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation.Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle.Cross-regulation of protein stability by p53 and nuclear receptor SHP.Nuclear receptor SHP inhibition of Dnmt1 expression via ERRγ.A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways.Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP.Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicinMicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.MicroRNA-206: a promising theranostic marker.Cyclin D1 is a major target of miR-206 in cell differentiation and transformation.Regulation of microRNA expression and function by nuclear receptor signaling.MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesisArsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9aNovel polymorphisms of nuclear receptor SHP associated with functional and structural changesLoss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.The downregulation of ATG4B mediated by microRNA-34a/34c-5p suppresses rapamycin-induced autophagy.MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT.
P2860
Q24319986-BAB30582-5CB7-49EF-9F07-910518334465Q26750448-F73CEE80-8BC8-46B8-B758-FD33BD4EE5CAQ26795757-63507F04-19C0-4FE1-9CAE-ECF67ABAD1F9Q26852591-4EE9EC92-1C62-4E4B-ADCC-7A7A4E0B6F1FQ27321524-B125A001-8C3A-4F89-82CD-D4502EA6821DQ28066233-7954D207-5ABE-4ED4-AF4F-C8611FE456F4Q28385924-58CCEADB-5C01-4491-823A-8CF1E61118C3Q28393225-90994E67-48D3-4F15-BCB2-5BD3373BC7FFQ30395192-54558382-0282-41CB-B1FB-C2432AFDC412Q33553774-35DCACC8-8724-4997-8A34-2BB441B717CAQ33924659-E1357545-3B7A-4062-9545-E27D3A0DE927Q34318481-54D31412-E556-4FE6-B452-53D29C753D56Q35099502-7DB11023-EE52-45CD-8AB8-1901C01426B7Q35942523-EB51518B-34AB-4C3F-9E30-C49A2238A0A2Q36008156-1668A305-697D-40E6-A771-F5197F0B07F2Q36966903-6820AF9E-8646-46F1-BA1B-390DF6AA814EQ37121662-EB00EA3B-7DD5-43AC-82D3-EBDDDB4524F1Q37189149-A51020DE-3FD8-4636-9608-F5801323742FQ37213847-DB095C94-7C91-4DEF-8699-56C7FB946F92Q37511094-F35FAA27-1960-4B1F-837D-D9ADDDB3988EQ37525842-6753D983-3494-4471-90AC-BBA72E38AF87Q37936584-C9463DCF-2730-4CFC-84E9-511DAF7BA95EQ37937737-F2664E58-D5C6-4D7A-9981-DDB58B5B4DC6Q38771636-9B89C21B-D45D-4743-B820-E34222A8D62EQ39951086-D6EA015C-CA36-43BD-8DD7-51F32656EBD1Q41495543-4524BC40-8928-4BF8-90F4-47684B1EB44FQ41879681-6B6E294D-2801-4945-A07C-3318881DFFA4Q42582367-06254CAB-D4E0-4327-9D48-0909F333694FQ46270590-66DA97F6-B22F-418C-9514-949FB5F6B3EBQ47138725-F884E8CF-15F6-4883-833C-FA552396C5E2Q50071627-2177EC63-8C94-42D3-A5A9-F7DE36766777Q53694593-F6802A84-BB77-45EF-A1AD-9B40A14F1EC7
P2860
Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@ast
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@en
type
label
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@ast
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@en
prefLabel
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@ast
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@en
P2860
P1433
P1476
Nuclear receptor SHP activates ...... ade dual inhibitory mechanism.
@en
P2093
Guisheng Song
P2860
P356
10.1371/JOURNAL.PONE.0006880
P407
P577
2009-09-01T00:00:00Z